Soraya Malekzadeh; Mei-Chan Chong; Li-Yoong Tang; Negar Omidi; Mahmoud Danaee
Volume 24, Issue 7 , 2022
Abstract
Background: Cardiac syndrome X(CSX) is a heart condition associated with Microvessel dysfunction, causing angina with severe chest pain. The CSX often severely impairs the quality of life and imposes a considerable additional cost burden on the health care system.
Objectives: The present study aimed ...
Read More
Background: Cardiac syndrome X(CSX) is a heart condition associated with Microvessel dysfunction, causing angina with severe chest pain. The CSX often severely impairs the quality of life and imposes a considerable additional cost burden on the health care system.
Objectives: The present study aimed to assess the effectiveness of mobile health (mHealth) intervention on health-related quality of life (HRQoL) among CSX patients.
Methods: This randomized control trial (RCT) study was conducted at the Clinic of Tehran Heart Centre from March to August 2019. A total of 100 CSX outpatients were selected by randomized sampling and assigned to the intervention (n=50) and control groups (n=50). This study was focused on the effectiveness of the mHealth intervention in HRQoL. The pre-test and post-test were conducted via questionnaires.
Results: Repeated measure MANOVA test for both groups across time pointed to a significant difference between the two groups in HRLQoL subscales at a 0.05 level of significance (F (3,95) = 7.358; P<0.001; Wilk's ? = 0.811, ?2= 0.189). The result indicated the positive effect of the intervention on HRQoL for CSX patients. Bonferroni test also revealed that the experimental and control groups did not differ significantly in three subscales of the questionnaire in the pre-test (P>0.05); nonetheless, they were significantly different in the post-test (P<0.05).
Conclusion: The HRQoL is considered an essential outcome measure in cardiac diseases, especially CSX, which is associated with impaired HRQoL. As evidenced by the results of the current study, the mHealth program, as a low-cost intervention, can promote the HRQoL among these patients.
Soraya Malekzadeh; Mei Chan Chong; Li Yoong Tang; Negar Omidi; Mahmoud Danaee
Volume 24, Issue 6 , 2022
Abstract
Background: Cardiac syndrome X (CSX) is a form of ischemic heart disease with functional coronary microvascular abnormalities. The symptoms are often debilitating and sufferers have a poor quality of life, with costly demand for healthcare services. Therefore, an educational intervention contributes ...
Read More
Background: Cardiac syndrome X (CSX) is a form of ischemic heart disease with functional coronary microvascular abnormalities. The symptoms are often debilitating and sufferers have a poor quality of life, with costly demand for healthcare services. Therefore, an educational intervention contributes to the increase of knowledge about CSX risk factors and adherence to a healthy lifestyle.
Objectives: This study aimed to investigate the effectiveness of educational interventions on knowledge and adherence to a healthy lifestyle in CSX Patients.
Methods: A simple, two-arm, parallel, randomized control trial was conducted in the Heart Clinic on 100 CSX outpatients who were selected through randomized sampling and divided into experimental (n=50) and control (n=50) groups. This study assessed an educational program that has been provided through the Mobile Health application (mHealth app) to the experimental group. The data were collected using the Heart Disease Fact Questionnaire (HDFQ) and Adherence to a Healthy lifestyle questionnaire (AHLQ).
Results: In the intervention group, the difference between the pre-test and post-test mean scores of knowledge on CSX risk factors was statistically significant (SD=1.77; P<0.05). However, there was no significant difference between pre-test and post-test means scores in the control group (SD=3.12; P>0.05).
Conclusion: Patients with CSX have high morbidity and health care expenditure; therefore, the provision of an educational program through the mHealth app as well as lifestyle modification can be considered a highly effective and low-cost intervention contributing to an increase of knowledge about CSX risk factors in patients and adoption of a healthy lifestyle.
